Published in Int J Eat Disord on May 01, 2008
Ghrelin: central and peripheral implications in anorexia nervosa. Front Endocrinol (Lausanne) (2013) 0.90
Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis (2007) 2.21
The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Clin Endocrinol (Oxf) (2007) 1.73
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab (2007) 1.53
Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet (2003) 1.47
Role of epigenetics in human aging and longevity: genome-wide DNA methylation profile in centenarians and centenarians' offspring. Age (Dordr) (2012) 1.33
Acromegaly. Pituitary (2006) 1.26
Isolated corticotrophin deficiency. Pituitary (2006) 1.11
Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab (2002) 1.11
Caution during use of desmopressin in IPSS. J Neurointerv Surg (2012) 1.07
Hypopituitarism. Pituitary (2006) 1.06
Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab (2003) 1.03
Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians' offspring. Aging (Albany NY) (2012) 1.01
Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series. J Clin Endocrinol Metab (2007) 0.99
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. Biotechnol Adv (2011) 0.98
Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J Clin Endocrinol Metab (2003) 0.98
Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab (2010) 0.95
Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Front Neuroendocrinol (2003) 0.93
Potential role for retinoic acid in patients with Cushing's disease. J Clin Endocrinol Metab (2012) 0.92
Growth hormone deficiency (GHD) in adult thalassaemic patients. Clin Endocrinol (Oxf) (2007) 0.92
Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Clin Endocrinol (Oxf) (2006) 0.90
Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. Cardiovasc Diabetol (2014) 0.90
Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure. Clin Endocrinol (Oxf) (2012) 0.89
Elastosonographic evaluation of thyroid nodules in acromegaly. Eur J Endocrinol (2009) 0.89
ACTH-secreting pheochromocytoma with false-negative ACTH immunohistochemistry. Endocr Pathol (2012) 0.88
Assessment of ACTH assay variability: a multicenter study. Eur J Endocrinol (2011) 0.87
MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency. J Clin Endocrinol Metab (2006) 0.86
Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. Clin Endocrinol (Oxf) (2006) 0.86
Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease. Br J Clin Pharmacol (2011) 0.85
Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma. J Clin Endocrinol Metab (2009) 0.85
Meningioma presenting with Cushing's syndrome: an unusual clinical presentation. Ann Neurol (2003) 0.84
Drugs and HPA axis. Pituitary (2008) 0.83
High prevalence of prolonged QT interval in obese hypogonadal males. Obesity (Silver Spring) (2011) 0.83
The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis. Eur J Endocrinol (2010) 0.82
Cushing's disease. Pituitary (2006) 0.81
[Is there any correlation between psychiatric disease and the teaching profession?]. Med Lav (2004) 0.81
The pituitary-adrenal axis in adult thalassaemic patients. Eur J Endocrinol (2009) 0.81
Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report. Endocr J (2010) 0.81
Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites. Clin Endocrinol (Oxf) (2008) 0.80
Immunomodulatory effects of VEGF: Clinical implications of VEGF-targeted therapy in human cancer. Cancer Biol Ther (2010) 0.80
Lymphocytes and immunoglobulin patterns across the threshold of severe obesity. Endocrine (2013) 0.80
Gender-dependent changes in haematological parameters in patients with Cushing's disease before and after remission. Eur J Endocrinol (2014) 0.79
Pericardial effusion requiring pericardiocentesis in a girl with anorexia nervosa. Int J Eat Disord (2006) 0.79
[Are teachers at risk for psychiatric disorders? Stereotypes, physiology and perspectives of a job prevalently done by women]. Med Lav (2009) 0.79
Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity. Eur J Endocrinol (2003) 0.78
Carney's complex with acromegaly as the leading clinical condition. Clin Endocrinol (Oxf) (2007) 0.78
Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease. Eur J Endocrinol (2007) 0.77
Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy. Clin Endocrinol (Oxf) (2012) 0.77
Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-up. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.77
A new therapeutic strategy against cancer: cAMP elevating drugs and leptin. Cancer Biol Ther (2009) 0.77
Pseudo-Cushing - A Clinical Challenge? Front Horm Res (2016) 0.77
Long-term echocardiographic and cardioscintigraphic effects of growth hormone treatment in adults with Prader-Willi syndrome. J Clin Endocrinol Metab (2015) 0.77
Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease. Clin Exp Pharmacol Physiol (2013) 0.77
AZA-deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors. Pituitary (2014) 0.76
Transsphenoidal surgery for Cushing's disease--importance of histopathology for prediction of outcome. Nat Clin Pract Endocrinol Metab (2008) 0.75
Advances in the medical management of Cushing's syndrome. Expert Opin Pharmacother (2008) 0.75
Differential diagnosis of ACTH-dependent hypercortisolism: imaging versus laboratory. Pituitary (2009) 0.75
Cushing's disease and pregnancy. Pituitary (2004) 0.75
Potential role of type I interferons in the treatment of pituitary adenomas. Rev Endocr Metab Disord (2008) 0.75